The Rising Crisis of Early-Onset Heart Disease
A recent study published in Scientific Reports in 2025 is shedding light on the alarming rise of early-onset Ischemic Heart Disease (IHD), by analyzing thirty years of data from 1990 to 2021. The study reports that while we have become better at treating heart attacks, we are failing to prevent them in the first place.
TL:DR
Global incidence and prevalence of early-onset IHD (ages 15–49) are rising, fueled by a global metabolic crisis—specifically obesity, poor diet, and high cholesterol. Modern medicine is keeping people alive longer after cardiac events, but public health is failing to stop young and middle-aged adults from getting sick.
Why you should care
Ischemic Heart Disease (IHD)—the leading cause of death among all types of cardiovascular diseases—is characterized by restricted blood flow to the heart primarily caused by atherosclerosis. While it is traditionally viewed as a condition for older adults, it is increasingly reported in the young and middle-aged population (15–49 years old).
This demographic is often not regarded as high-risk, meaning they easily slip through the critical stage where preventive measures are most effective. In 2021 alone, early-onset IHD was responsible for over 30.4 million DALYs (Disability-Adjusted Life Years) globally. This early onset results in:
Prolonged morbidity and higher risks of recurrence and mortality.
Severe emotional and financial strains on families.
Long-term demand for chronic care and repeated hospitalizations.
Reduced workplace productivity due to absenteeism and even unemployment
The Great Statistical Paradox
One of the most striking findings in the report is a clear divergence in health trends: while Age-Standardized Mortality Rates (ASMR) and Age-Standardized DALYs Rates (ASDR) have decreased globally over the last 30 years, Age-Standardized Prevalence Rates (ASPR) and Incidence Rates (ASIR) are on the rise.
What does this actually mean? It means that advancements in medical technology—such as primary percutaneous coronary intervention (PPCI) and digital health monitoring (IoT)—are successfully keeping people alive after a heart attack. However, because we aren't preventing the disease from starting, the total number of people living with chronic IHD is accumulating. Modern medicine is winning the battle against death, but public health is losing the battle against disease.
Metabolism and Obesity: The Driving Forces
The risk factors for early-onset IHD are modifiable and proactively preventable. In 2021, the top five risk factors for DALYs globally were dietary risks, high LDL cholesterol, high systolic blood pressure, tobacco, and air pollution.
The Metabolic Crisis:
The Obesity Epidemic: To date, no country has successfully curbed the rising prevalence of overweight and obesity. As a result, the burden of early-onset IHD attributable to high Body Mass Index (BMI) has risen across all socioeconomic levels over the past 30 years.
The Gender Gap: The rise in incidence and prevalence has been faster in women than in men over the last three decades. Researchers suggest this is partially due to higher obesity rates in women, with high BMI accounting for 18.21% of their disease burden compared to 16.10% in men.
Diet and LDL: Unhealthy dietary patterns and high LDL cholesterol were identified as the two most significant risk factors for both men and women across all regions.
The Rise of Diabetes: Rising high fasting plasma glucose (diabetes) cases are a key driver of escalating IHD incidence, particularly in regions undergoing rapid urbanization and "dietary westernization," such as North Africa and the Middle East.
The Path Forward: Prevention is Possible
Because early-onset IHD is highly preventable, improving dietary habits and controlling blood lipids can yield massive benefits. The report emphasizes that younger patients who receive proactive management achieve much better clinical outcomes than older counterparts.
To address this challenge, the report suggests:
Establishing community-based screening programs for hypertension and diabetes.
Implementing dietary policies regarding salt and trans-fat reduction.
Creating widespread weight management programs.
Improving access to affordable cardiovascular medications.
What This Means for You
While the rising incidence of heart disease in younger people is discouraging news, it also shows the massive potential for improvement by implementing just small, key checks early on. The importance lies in strengthening awareness and enabling informed lifestyle changes before a crisis occurs.
We must shift our focus from just surviving a heart attack to preventing the damage from ever starting.
Because in the end, the goal of longevity is not a long life in sickness, but a long life in health.
DALY = the time lost due to premature death and the time lived with a disability, thus quantifying the overall burden of disease
Incidence = rate of new cases of a disease within a specific population over a given time period
Prevalence = total number of people currently living with the disease at a given point in time regardless of when they were first diagnosed
Song, J., Yuan, K., Huang, Y., Chen, Z., Wang, X., Wang, Z., & Zhang, L. (2025). Global, regional, and national burden of ischemic heart disease in young and middle-aged population from 1990 to 2021. Scientific Reports, 15(41982). https://doi.org/10.1038/s41598-025-26248-x